Spectrum Pharma (SPPI), Sandoz Enter Settlement Over Folotyn Patent Litigation
Tweet Send to a Friend
Spectrum Pharma (NASDAQ: SPPI) disclosed the following onItem 8.01 Other Events.On June 8, 2016, a wholly-owned subsidiary of Spectrum Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
